Quarterly report · Q3
3034.TEDINET S100SVU6
Period2023-04-01 → 2023-12-31
Filed2024-02-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥134.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net sales |
| Revenue | ¥170.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥126.1bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥5.7bn | 2023-04-01 → 2023-12-31 | Cons. | Operating income |
| Operating income | ¥6.8bn | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥6.5bn | 2023-04-01 → 2023-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥10.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥6.5bn | 2023-04-01 → 2023-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥7.1bn | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥3.8bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss |
| Net income | ¥4.2bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥115.9bn | at 2023-12-31 | Cons. | Assets |
| Total assets | ¥101.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥105.5bn | at 2022-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥64.2bn | at 2023-12-31 | Cons. | Liabilities |
| Total liabilities | ¥53.0bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥51.7bn | at 2023-12-31 | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥47.3bn | at 2022-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥23.2bn | at 2023-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥18.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥101.47 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥50.64 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥152.96 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.57 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥48.43 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 44.5% | at 2023-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.8% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥373m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥373m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥2.7bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥123.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥123.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥76m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥7.6bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥11.6bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥11.3bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥296m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥884m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥134.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥134.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥373m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥8.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥317m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥2.6bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥115.4bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥115.3bn |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥66m |
| jpcrp040300-q3r_E03476-000Health Insurance Pharmacyreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥11.1bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥10.8bn |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥250m |
| jpcrp040300-q3r_E03476-000Medical Relatedreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.2bn |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥126.4bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥126.1bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥317m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥9.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 369
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)田 中 淳 一 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)渡 邊 崇 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 126101000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 134528000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 170036000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 7094000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 6523000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 10098000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 4158000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 3774000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 5656000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 4160000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 3780000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 5657000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 47291000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 51675000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 48856000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 105544000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 115922000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 101905000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 112.57 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 101.47 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 152.96 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.448 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.445 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.479 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 48.43 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 50.64 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 38902785 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 38902785 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 38902785 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 1200200 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 37672500 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 376725 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 30085 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 38902785 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 376725 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 1200200 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |